VisuMix M
Natural health product licensed in Canada
- Licence holder
- Lusante Inc.
- NPN or DIN-HM
- 80110563
- Status
- Active licence
- Licence date
- 8 June 2021
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 20 mg AT | Not calculated |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 30 UI | Not calculated |
| Zinc Source : Oxyde de zinc | 10 mg | Not calculated |
| (3R,3'R,6'R)-bêta,epsilon-carotène-3,3'-diol Source : Lutéine | 10 mg | Not calculated |
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxychromen-4-one Source : Quercétine | 20 mg | Not calculated |
| Cuivre Source : Cuivre | 1 mg | Not calculated |
| L-Glutathione Source : Glutathione | 50 mg | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 250 mg Potency : 40 % Proanthocyanidins | 25 mg | Not calculated |
| (3R,3'R)-bêta,bêta-Carotène-3,3'-diol Source : Zeaxanthin | 2 mg | Not calculated |
| Vaccinium myrtillus Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 800 mg Potency : 25 % Anthocyanins | 80 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 100 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Phosphate de calcium, dibasique, dihydraté, Dioxyde de silicium, Cellulose microcristalline, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 par jour |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to improve macular pigment optical density. Helps to maintain eyesight/support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Source of/Provides antioxidants for the maintenance of eye health. Source of/Provides antioxidants. Helps to maintain/support eyesight in certain conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to maintain eyesight and in the development and maintenance of night vision. Used in Herbal Medicine to help slow the progression of disorders of the eye, such as diabetic and hypertensive retinopathy, and macular degeneration.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80110563
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.